ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 172

Optimizing Precision Medicine By Using Genetics to Assign Diagnostic Prior Probabilities to Patients with Synovitis

Rachel Knevel1,2,3,4, Chikashi Terao5,6,7, Jing Cui1,8, Kamil Slowikowski2,9,10, TWJ Huizinga3, Elizabeth Karlson11 and Soumya Raychaudhuri1,2,12,13, 1Division of Medicine and Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Medical and Population Genetics Program, Broad Institute of MIT and Harvard, Cambridge, MA, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Bosten, MA, 5Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 6Clinical Research Center, Shizuoka General Hospital, Shizuoka, Japan, 7Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 8Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 9Division of Medicine and Rheumatology, Brigham and Women's Hospital, Harvard Medical Schoo, Boston, MA, 10Division of Genetics, Brigham and Women's Hospital, Harvard Medical Schoo, Boston, MA, 11Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 12Department of Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom, 13Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: Diagnostic Tests, genetics, rheumatologic practice and risk assessment

Session Information

Date: Sunday, November 5, 2017

Title: Genetics, Genomics and Proteomics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

As the cost of genome-wide genotyping plummets, and biobanking efforts integrating medical records and genetics are rapidly expanding, many patients will have genotyping available in medical records prior to patient visits. The question emerges: how informative this data is in a rheumatology clinic.

This study tests the potential for genetics to assign prior probabilities for six synovitis phenotypes; ACPA positive rheumatoid arthritis, ACPA negative rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriatic arthritis and gout.

Methods:

Risk allele information was obtained from Immunobase and GWAS publications. The genetic probability (GP) for each phenotype was calculated using Bayesian theorem with the summation of the risk alleles times the risk effects of each genetic variant as the likelihood and the sex adjusted disease prevalence as the prior. The GPs were normalized so that the total of the six probabilities for each individual was one. If GPs are accurate we expect that the percent of individuals that have a disease tracks with GP.

I Benchmarking performance by simulation

We simulated a population of one million people with random genotypes using minor allele frequencies from the 1000 genome project. We randomly assigned phenotypic status based on the known genetic risk alleles, sex, and disease prevalence. We then scored all individuals with disease for posterior probabilities.

II Validation

We selected clinical cases on their ultimate diagnosis from BostonÕs Partners BIOBANK, using a rule-based algorithm based on clinical notes, lab tests and medication prescriptions.

Results:

I In the simulation data set we observed that GPs were concordant with the phenotypic status, demonstrating that our model works in a theoretical dataset.

II We identified 297 out of the 15,000 patients in the BIOBANK that had one of the six diseases of interest. We used these individuals and assessed the performance of the GP.

We observed that there was a high positive correlation between the GP and the clinical case risk for the phenotypes (r2 = 0.95). A high GP correctly corresponded with the clinical phenotypes: in all cases where the probability > 0.9, the patient indeed had that phenotype. More importantly, the GP could discard phenotypes:  GPs < 0.1 correctly corresponded with a clinical disease risk of < 10%, whereby for all individuals 1-4 phenotypes could be effectively ruled out. We note however that the GP (mean 0.24) somewhat overestimated the clinical risk (mean 0.16).

Conclusion:

In a cohort of synovitis patients, genetic information can facilitate decision making in early disease by ruling out and pointing towards the most likely phenotype. Seeing the importance of an early diagnosis in patients presenting with synovitis, genetics can be considered as part of a patientÕs medical history and as such it can inform us about the most likely diagnosis, without having to wait for more symptoms to arise.


Disclosure: R. Knevel, None; C. Terao, None; J. Cui, None; K. Slowikowski, None; T. Huizinga, Abbott Laboratories, Biotest AG, Bristol-Myers Squibb, Crescendo Bioscience, Novartis Pharmaceuticals Corporation, Pfizer Inc, Roche, sanofi-aventis, Schering-Plough, UCB, Eli Lilly, 5,METEOR Board, 6,EU & Dutch Arthritis Foundation, 2,Abbott Laboratories, Biotest AG, Bristol-Myers Squibb, Novartis Pharmaceuticals Corporation, Pfizer Inc, Roche, sanofi-aventis, Schering-Plough, 8,Abbott Laboratories, Roche, 9; E. Karlson, None; S. Raychaudhuri, Pfizer Inc, 2,Roche Pharmaceuticals, 2.

To cite this abstract in AMA style:

Knevel R, Terao C, Cui J, Slowikowski K, Huizinga T, Karlson E, Raychaudhuri S. Optimizing Precision Medicine By Using Genetics to Assign Diagnostic Prior Probabilities to Patients with Synovitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/optimizing-precision-medicine-by-using-genetics-to-assign-diagnostic-prior-probabilities-to-patients-with-synovitis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/optimizing-precision-medicine-by-using-genetics-to-assign-diagnostic-prior-probabilities-to-patients-with-synovitis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology